Chordoma - 22 Studies Found Completed : Nivolumab With or Without Stereotactic Radiosurgery in Treating Patients With Recurrent, Advanced, or Metastatic Chordoma : Chordoma : 2016-12-08 : Other: Laboratory Biomarker Analysis Completed : The National Cancer Institute Opens A Randomized, Double-Blind, Phase 2 Trial of GI-6301 (Yeast-Brachyury Vaccine) Versus Placebo in Combination With Standard of Care Definitive Radiotherapy in Locally Advanced, Unresectable, Chordoma : Chordoma : 2015-03-04 : Other: GI-6301 Placebo GI-6301 Completed : Hypoxia-positron Emission Tomography (PET) and Intensity Modulated Proton Therapy (IMPT) Dose Painting in Patients With Chordomas : Chordoma : 2008-07-09 : Procedure: Fluoromisonidazole-PET/CT 2 scans at different time intervals: 2 weeks before and 3 weeks aft Completed : Improvement of Local Control in Skull Base, Spine and Sacral Chordomas Treated by Surgery and Protontherapy Targeting Hypoxic Cells Revealed by [18F]FAZA) PET/CT Tracers : Skull Base Chordoma Vertebral Chordoma : 2016-06-03 : Procedure: Surgery Recruiting : Genetic Clues to Chordoma Etiology: A Protocol to Identify Sporadic Chordoma Patients for Studies of Cancer-Susceptibility Genes : Genes Sporadic Chordoma : 2010-09-09 Completed : Trial of Proton Versus Carbon Ion Radiation Therapy in Patients With Chordoma of the Skull Base : Chordoma Tumor Treatment : 2010-07-26 : Radiation: Carbon ion Completed : A Study of IMRT in Primary Bone and Soft Tissue Sarcoma : Soft Tissue Sarcoma, Adult Ewing Sarcoma Bone Sarcoma : 2015-07-31 : Radiation: Intensity modulated radiotherapy (IMRT) Intensity modulated radiotherapy (IMRT) is an advance Recruiting : Polyvinylpyrrolidone-Sodium Hyaluronate Gel in Reducing Pain From Oral Mucositis in Young Patients With Cancer : Brain and Central Nervous System Tumors Chordoma : 2006-07-05 : Drug: polyvinylpyrrolidone-sodium hyaluronate gel Terminated : Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors : Brain and Central Nervous System Tumors Childhood Germ Cell Tumor Drug: amifostine trihydrate Active, not recruiting : Trial of Dasatinib in Advanced Sarcomas : Rhabdomyosarcoma Malignant Peripheral Nerve Sheath Tumors : 2007-04-20 : Drug: Dasatinib oral agent, continuous dosing, Cycles = 28 days <<< Previous | Next >>>
